ライフサイエンスコーパス: CBT

1 CBT as an adjunct to usual care that includes antidepres

2 CBT is effective in reducing fatigue severity in QFS pat

3 CBT seems to be effective in patients after self-harm.

4 CBT-I and TCC groups showed robust improvements in sleep

5 CBT-I may exert its treatment effects on PI by reducing

6 osocial intervention group (n=6 [IQR 4-11]), CBT group (n=9 [5-14]), and short-term psychoanalytical

7 randomly assigned to receive MBSR (n = 116), CBT (n = 113), or usual care (n = 113).

8 the brief psychosocial intervention (n=158), CBT (n=155), or short-term psychoanalytical therapy (n=1

9 reat analysis (doxycycline, 52; placebo, 52; CBT, 50).

10 t of tDCS on clinical outcome over and above CBT (active: 50%; sham: 31.6%; odds ratio: 2.16, 95% CI

11 Adapting CBT to target acute pain management in the post-operativ

12 remission with CBT, escitalopram was added (CBT plus medication group) to their treatment, and for t

13 not achieve remission with CBT, as is adding CBT after antidepressant monotherapy.

14 After CBT, significant clinical improvements in the patient gr

15 response to visual SS in PI before and after CBT-I.

16 26% for every 10-point increase in AUC after CBT (hazard ratio [HR], 0.974; P < .0001).

17 BOLD changes after CBT-I in patients were also examined.

18 .26; P < .0001) and lower ATG exposure after CBT (HR, 1.005; P = .0071).

19 Clinical improvements after CBT-I were correlated with BOLD reduction in the right i

20 tigue severity was significantly lower after CBT (31.6 [95% CI, 28.0-35.1]) than after placebo (diffe

21 U was associated with higher mortality after CBT, which may be a useful criterion for CBU selection,

22 brain hyper-responses were normalized after CBT-I.

23 in panic disorder, which is normalized after CBT.

24 increased responses to SS were reduced after CBT-I.

25 sleep onset (WASO), and its reduction after CBT-I was associated with improvements in WASO.

26 choice for psychological therapy, alongside CBT, for adolescents with moderate to severe depression

27 ith nonrecurrence at the second winter among CBT-SAD participants (relative risk=5.12) compared with

28 compared with TAU or wait-list control, and CBT also reduced suicide attempts compared with TAU.

29 or joint treatment with both fluoxetine and CBT.

30 randomized between oral study medication and CBT (2:1) for 24 weeks.

31 The combination of sertraline and CBT significantly reduced clinician-reported primary anx

32 f threat predict better response to SSRI and CBT treatment in anxious youth and that neuroimaging may

33 Results showed that both SSRI and CBT treatments similarly attenuated insula and amygdala

34 otion perception is reduced by both SSRI and CBT treatments, and predicts anxiety and depression symp

35 representatives of psychodynamic therapy and CBT, the main rival psychotherapeutic treatments (advers

36 ot achieve remission with an antidepressant, CBT was added (medication plus CBT group) to their treat

37 e counselling using the Life-Steps approach (CBT-AD) has an emerging evidence base.

38 psychoanalytical therapy was as effective as CBT and, together with brief psychosocial intervention,

39 e psychosocial depression treatments such as CBT-AD to people living with HIV/AIDS and examine the co

40 ho were screened, 90 were randomly assigned (CBT-I: n = 45; TCC: n = 45).

41 first time a sustained increased astronauts' CBT also under resting conditions.

42 To evaluate a web-based, automated CBT-I intervention to improve insomnia in the short term

43 hy control subjects) after an exposure-based CBT.

44 Conclusion Internet-based CBT has salutary effects on sexual functioning, body ima

45 y assigned 169 BCSs to either Internet-based CBT or a waiting-list control group.

46 -intensity computerised CBT (cCBT; web-based CBT materials and limited telephone support) through "OC

47 lephone CBT (telephone-CBT group), web-based CBT with minimal therapist support (web-CBT group), or t

48 orm, and posterior cingulate cortices before CBT-I.

49 Irreversible condensation between CBT derivatives and N-terminal cysteine residues has bee

50 ne (S4) were significantly different between CBT and both MSCs (P < 0.05) and indicated greater insta

51 During the reaction between CBT and aminothiols, we resolved two transient intermedi

52 Both CBT and DBT showed modest benefit in reducing suicidal i

53 In conclusion, both CBT and PDT appear to potentially offer some benefit for

54 ll-being, function and resource use for both CBT and PDT.

55 tained improvements in IBS were seen in both CBT groups compared with TAU, although some previous gai

56 rtain effect on cardiovascular outcomes, but CBT combined with antidepressant medication produces mod

57 insula connectivity that are not targeted by CBT alone.

58 ilization potential of carboxybenzotriazole (CBT) and methylbenzotriazole (MeBT), where these derivat

59 ized GACs saturated with carboxybenzotrzole (CBT), which reached a maximum elimination for U(VI) at 2

60 ntly in randomized clinical trials comparing CBT and pharmacotherapy for depression.

61 Long-term trials comparing CBT and SGA are lacking.

62 s received 1 of 2 low-intensity computerised CBT (cCBT; web-based CBT materials and limited telephone

63 Conclusion CBT-I and TCC produce clinically meaningful improvements

64 rvention effects were found for contemporary CBTs that were focused on processes of cognition-for exa

65 criteria for noninferiority to conventional CBT at week 16.

66 Conversely, CBT has been relatively disappointing in follicular lymp

67 tion between 6-hydroxy-2-cyanobenzothiazole (CBT) and cysteine has been shown for various application

68 tic investigation into 2-cyanobenzothiazole (CBT) chemistry within a protein nanoreactor.

69 tein purification with 2-cyanobenzothiazole (CBT) condensation for labeling a proteolytically exposed

70 Conjugation of 2-cyanobenzothiazole (CBT) with N-terminal cysteines (NCys) typically gives a

71 They hypothesized that coach-delivered CBT-GSH telemedicine sessions plus Noom Monitor would yi

72 Internet-delivered CBT-I has shown promise as a method to overcome this obs

73 fficacy and availability, internet-delivered CBT-I may have a key role in the dissemination of effect

74 nts to receive brief guided parent-delivered CBT (n=68) or solution-focused brief therapy (n=68).

75 hildren in the brief guided parent-delivered CBT group versus 47 (69%) children in the solution-focus

76 However, guided parent-delivered CBT is likely to be a cost-effective alternative to solu

77 ol, to receive brief guided parent-delivered CBT or solution-focused brief therapy, with minimisation

78 However, brief guided parent-delivered CBT was associated with lower costs (mean difference - p

79 superiority of brief guided parent-delivered CBT.

80 28.0-35.1]) than after placebo (difference, CBT vs placebo, 6.2 [97.5% CI, .5-11.9]; P = .03).

81 ssigned 3755 participants to receive digital CBT for insomnia (n=1891) or usual practice (n=1864).

82 aloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-pro

83 Participants received eight CBT-GSH telemedicine sessions over 12 weeks administered

84 aseline and 12 weeks later, following either CBT or SSRIs in the patient sample.

85 ine structural MRI scans and received either CBT or SSRI treatment.

86 as the study was conducted in an established CBT clinic and the chief investigator is the originator

87 fects in treating depression that may exceed CBT.

88 We here show that during exercise CBT rises higher and faster in space than on Earth.

89 Face-to-face CBT leads to quicker and greater reductions in the numbe

90 icipants received 20 individual face-to-face CBT sessions of 50 minutes each or sequentially complete

91 orporated the primary tenets of face-to-face CBT-I.

92 ed with traditional, individual face-to-face CBT.

93 R genotyping in graft selection criteria for CBT.

94 s C range, with peak values being higher for CBT than for both MSCs.

95 Fifty-two-week outcomes for CBT-GSH plus Noom Monitor (N=114) were compared with out

96 ed to define subsets that might benefit from CBT.

97 differ significantly between patients given CBT and those given short-term psychoanalytical therapy

98 sized pattern of response: joint treatment > CBT or fluoxetine treatment > placebo treatment.

99 telemedicine trial of CBT-guided self-help (CBT-GSH) assisted with a smartphone app, Noom Monitor, f

100 cacy of CBT-I, little is known regarding how CBT-I works at a cellular and molecular level to improve

101 follow-up data in the majority of identified CBT trials.

102 Checkpoint blockade immunotherapy (CBT) has revolutionized cancer treatment; however, the c

103 ing MCT 74% of patients compared with 52% in CBT met formal criteria for recovery on the BDI-II at po

104 response at 15 months was 43.7% and 46.7% in CBT-I and TCC, respectively.

105 s, insomnia remission was 46.2% and 37.9% in CBT-I and TCC, respectively.

106 treatment decisions regarding engagement in CBT or SSRIs, especially among individuals with an enhan

107 Since even minor increases in CBT can impair physical and cognitive performance, both

108 ere more frequent in pharmacotherapy than in CBT.

109 BT was planned to be about one-third that in CBT.

110 t with either an SGA or group and individual CBT.

111 e Cognitive behavioral therapy for insomnia (CBT-I) and Tai Chi Chih (TCC), a movement meditation, im

112 ugh cognitive behavior therapy for insomnia (CBT-I) has been established as the first-line recommenda

113 Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for insomnia; a key c

114 y cognitive behavioral therapy for insomnia (CBT-I).

115 ncerns the level of access to high-intensity CBT before the primary outcome assessment.

116 icant reductions in uptake of high-intensity CBT over 12 months; 86% of the patients allocated to the

117 cated to the waiting list for high-intensity CBT started treatment by the end of the trial, compared

118 of low-intensity CBT prior to high-intensity CBT, in adults meeting the Diagnostic and Statistical Ma

119 al effectiveness of 2 forms of low-intensity CBT prior to high-intensity CBT, in adults meeting the D

120 The internet CBT-I (Sleep Healthy Using the Internet [SHUTi]) was a 6

121 omized clinical trial comparing the internet CBT-I with internet patient education at baseline, 9 wee

122 A)-might be as effective and cheaper than is CBT.

123 nts were on a waiting list for therapist-led CBT (treatment as usual).

124 efits but may reduce uptake of therapist-led CBT.

125 ntribute to OCD pathophysiology and moderate CBT outcomes.

126 Neither SGAs nor CBT provides consistently superior cost-effectiveness re

127 , compared with placebo, fluoxetine (but not CBT) was significantly more effective at week 24 in redu

128 Here, we present two novel CBT trisamides with (S)- or (R)-chiral side chains which

129 Trace amounts of CBT were observed in some column effluents, but this did

130 d-cycloserine augmentation of CBT did not confer additional benefit relative to placeb

131 to investigate the neurobiological basis of CBT-I, and provides a platform that can be exploited tow

132 Pooled results for the benefit of CBT for pregnant and postpartum women with screen-detect

133 energy transfer (BRET) to detect binding of CBT-labeled growth factors to their cognate receptors ge

134 was noninferior to a conventional course of CBT that provided over 8 additional hours of therapist c

135 A significant effect of CBT during continuation of antidepressant drugs compared

136 Evidence supports the effectiveness of CBT and SSRIs for reducing childhood anxiety symptoms.

137 demonstrated the remarkable effectiveness of CBT in specific lymphoma subtypes, including classical H

138 This study investigated the effects of CBT on the behavioral and neural correlates of the panic

139 ed (1) whether tDCS improved the efficacy of CBT relative to sham stimulation; and (2) whether neural

140 im of this study was to test the efficacy of CBT-AD.

141 Despite the well-documented efficacy of CBT-I, little is known regarding how CBT-I works at a ce

142 lts showed that, at 12 months, both forms of CBT for IBS were significantly more effective than treat

143 randomised, controlled trial of two forms of CBT for patients with refractory IBS.

144 ipants were randomly assigned to 3 months of CBT-I or TCC and evaluated at months 2, 3 (post-treatmen

145 This alternative reaction pathway of CBT-NCys condensation presents a significant addition to

146 (PePS) intervention, based on principles of CBT, to determine feasibility and preliminary efficacy f

147 We found no evidence for the superiority of CBT or short-term psychoanalytical therapy compared with

148 inal analyses also showed the superiority of CBT over GSH-I by the 6-month (adjusted effect, 0.36; 95

149 randomized controlled telemedicine trial of CBT-guided self-help (CBT-GSH) assisted with a smartphon

150 Use of CBT-I improved several sleep outcomes in older adults (l

151 rsus control visit (phase 1) and 12 weeks of CBT delivered in the dialysis facility versus sertraline

152 d trial-were re-scanned after 12-14 weeks of CBT or after 8 weeks of minimal-contact waitlist; waitli

153 third scan after crossover to 12-14 weeks of CBT.

154 vity, clothing, and environmental factors on CBT regulation under terrestrial conditions.

155 the effects of long-duration spaceflight on CBT at rest and during exercise are clearly lacking.

156 s a surface temperature proxy, or MBT and/or CBT for reconstructing pH, in anoxic or euxinic lakes, e

157 roscopy (MRS) was associated with OCD and/or CBT response.

158 erated code, to receive either usual care or CBT in addition to usual care.

159 10-20 mg/day), duloxetine (30-60 mg/day), or CBT (16 50-minute sessions).

160 gned to receive escitalopram, duloxetine, or CBT monotherapy and completed 12 weeks of treatment with

161 dicated whether they preferred medication or CBT or had no preference.

162 one-half of subjects following sertraline or CBT.

163 The combined OCD participants (CBT-only plus waitlist-CBT) also showed a 16.2% (p=0.004

164 assigned to one of four treatments-placebo, CBT, fluoxetine, or joint treatment with both fluoxetine

165 verity indicated that the d-cycloserine plus CBT group and the placebo plus CBT group declined at sim

166 (89%) was higher than in the medication plus CBT group (53%).

167 tidepressant, CBT was added (medication plus CBT group) to their treatment.

168 loserine plus CBT group and the placebo plus CBT group declined at similar rates per assessment point

169 clinician-rated anxiety symptoms pre-to-post CBT and SSRI treatment among youth with current anxiety.

170 clinician-rated anxiety symptoms pre-to-post CBT and SSRI treatment.

171 list-CBT) also showed a 16.2% (p=0.004) post-CBT decrease in pACC Glu.

172 connectivity and OCD symptoms pre- and post-CBT were examined using longitudinal cross-lagged panel

173 CC, lower pre-CBT Glu predicted greater post-CBT improvement in symptoms (CY-BOCS; r=0.81, p=0.00025)

174 ared to current best psychotherapy practice, CBT, in adults with major depressive disorder.

175 e combined OCD group, within vPCC, lower pre-CBT Glu predicted greater post-CBT improvement in sympto

176 In model projections, CBT produced higher QALYs (3 days more at 1 year and 20

177 Cognitive-behavioural-based psychotherapy (CBT; comprising cognitive-behavioural and problem-solvin

178 N=85) were then randomly assigned to receive CBT paired with either active or placebo ABMT.

179 ety symptoms within individuals who received CBT but not SSRIs.

180 o treatment, particularly those who received CBT plus placebo ABMT.

181 rder, or separation anxiety and who received CBT, pharmacotherapy, or the combination.

182 Participants who received CBT-GSH plus Noom Monitor reported significant reduction

183 IBS-specific CBT has the potential to provide long-term improvement i

184 omly assigned to either 16 weeks of standard CBT (up to 20 sessions of 50 minutes each) or CCBT using

185 receive either therapist-delivered telephone CBT (telephone-CBT group), web-based CBT with minimal th

186 therapist-delivered telephone CBT (telephone-CBT group), web-based CBT with minimal therapist support

187 (1.3 to 4.9; p<0.001) lower in the telephone-CBT group and 1.9 points (0.1 to 3.7; p=0.036) lower in

188 5.0 to 66.0; p=0.002) lower in the telephone-CBT group and 12.9 points (-12.9 to 38.8; p=0.33) lower

189 between 12 to 24 months: 11 in the telephone-CBT group, 15 in the web-CBT group, and 15 in the TAU gr

190 ticipants: 119 (64%) of 186 in the telephone-CBT group, 99 (54%) of 185 in the web-CBT group, and 105

191 4 (71%) of 119 participants in the telephone-CBT group, in 62 (63%) of 99 in the web-CBT group, and i

192 Humans' core body temperature (CBT) is strictly controlled within a narrow range.

193 sleep disruption, or core body temperature (CBT).

194 no evidence that IPT was less effective than CBT.

195 These results suggest that CBT-GSH plus Noom Monitor delivered via telemedicine by

196 The CBT consisted of weekly therapist-guided sessions, with

197 QOLIE-89 scores was significant for both the CBT (25.7%; p < 0.001) and sertraline (28.3%; p < 0.001)

198 groups (intent-to-treat rates, 41.6% for the CBT group and 42.9% for the CCBT group).

199 ed with the CBT plus placebo ABMT group, the CBT plus active ABMT group exhibited less severe anxiety

200 95% CI = +/-11.6) of the 68 subjects in the CBT group achieved remission; the lower bound of efficac

201 s completed the 16-week protocol (79% in the CBT group and 82% in the CCBT group).

202 ic findings were significantly higher in the CBT group than in the GSH-I group at 6-month follow-up (

203 achieve remission, the remission rate in the CBT plus medication group (89%) was higher than in the m

204 ere more frequent in the sertraline than the CBT group.

205 uency (15-30 Hz) oscillations throughout the CBT network.

206 Compared with the CBT plus placebo ABMT group, the CBT plus active ABMT gr

207 contemporary cognitive behavioral therapies (CBTs; g = 0.42) were larger than those of traditional CB

208 f sertraline and cognitive behavior therapy (CBT) for depression, quality of life, seizures, and adve

209 combination of cognitive behavioral therapy (CBT) and antidepressant medication improved depression s

210 erse events of cognitive behavioral therapy (CBT) and pharmacotherapy for childhood anxiety disorders

211 FC)] predicted cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) t

212 he efficacy of cognitive-behavioral therapy (CBT) and two antidepressant medications (escitalopram an

213 Cognitive behavioral therapy (CBT) can reduce distress and improve functioning among p

214 Cognitive-behavioral therapy (CBT) has been hypothesized to act by reducing the pathol

215 remission with cognitive-behavioral therapy (CBT) has received little study.

216 Cognitive-behavioral therapy (CBT) has shown efficacy in the treatment of eating disor

217 doxycycline or cognitive-behavioral therapy (CBT) in reducing fatigue severity in patients with QFS.

218 Cognitive-behavioral therapy (CBT) is effective for pediatric obsessive-compulsive dis

219 apy (ABMT) and cognitive-behavioral therapy (CBT) may have complementary effects by targeting differe

220 Internet-based cognitive behavioral therapy (CBT) on sexual functioning and relationship intimacy (pr

221 choice between cognitive-behavioral therapy (CBT) or an antidepressant medication for treatment-naive

222 change during cognitive-behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRIs).

223 suggests that cognitive behavioral therapy (CBT) reduces suicide attempts, suicidal ideation, and ho

224 Although cognitive behavioral therapy (CBT) represents the criterion standard for treatment of

225 armacotherapy, cognitive-behavioral therapy (CBT), and psychodynamic therapy are most frequently appl

226 ed a course of cognitive-behavioral therapy (CBT).

227 herapy and for cognitive-behavioral therapy (CBT).

228 on to standard cognitive-behavioral therapy (CBT).

229 rs (SSRIs) and cognitive-behavioral therapy (CBT).

230 ssant (SGA) or cognitive behavioral therapy (CBT).

231 High-intensity" cognitive-behaviour therapy (CBT) from a specialist therapist is current "best practi

232 12 examining cognitive behavioural therapy (CBT) and 7 investigating psychodynamic therapy (PDT).

233 Integrating cognitive behavioural therapy (CBT) for depression with adherence counselling using the

234 ceive digital cognitive behavioural therapy (CBT) for insomnia or usual care, and the research team w

235 Cognitive behavioural therapy (CBT) is recommended in guidelines for refractory IBS but

236 e, to receive cognitive behavioural therapy (CBT) or short-term psychoanalytical therapy versus a ref

237 ent-delivered cognitive behavioural therapy (CBT) would be associated with better clinical outcomes t

238 edication and cognitive behavioural therapy (CBT), are ineffective for many patients.

239 enced therapy-cognitive behavioural therapy (CBT)-is complex and costly.

240 ivity to immune checkpoint blockade therapy (CBT).

241 85 were randomly allocated to MCT and 89 to CBT.

242 tory IBS but there is insufficient access to CBT for IBS and uncertainty about whether benefits last

243 Increasing access to CBT for IBS could achieve long-term patient benefit.

244 harmacotherapy, increasing patient access to CBT may be warranted.

245 Patients randomly assigned to CBT who had antidepressants tapered and discontinued wer

246 tcomes of remission and treatment failure to CBT and antidepressant medication and survived applicati

247 ntion-to-treat sample, GSH-I was inferior to CBT in reducing OBE days at the end of treatment (adjust

248 feriority showed that TCC was noninferior to CBT-I at 15 months ( P = .02) and at months 3 ( P = .02)

249 , we evaluated whether TCC is noninferior to CBT-I for the treatment of insomnia in survivors of brea

250 was found to be statistically noninferior to CBT-I, the gold standard for behavioral treatment of ins

251 tered to the left prefrontal cortex prior to CBT.

252 remained stable among patients randomized to CBT and healthy controls.

253 from scan-to-scan for patients randomized to CBT, with minor increases (3.8%) for waitlist participan

254 eatening faces predicted greater response to CBT and SSRI treatment.

255 cale network regions may predict response to CBT in pediatric OCD, highlighting the clinical relevanc

256 ft frontal pole predicted better response to CBT in the OCD group.

257 observation of enhanced clinical response to CBT plus active ABMT.

258 e was associated with subsequent response to CBT, irrespective of tDCS.

259 ysiology of OCD and may moderate response to CBT.

260 importance is differential responsiveness to CBT across different tissue sites of tumor growth.

261 f biomarkers that predict for sensitivity to CBT in lymphoma patients.

262 environment and ultimately, vulnerability to CBT.

263 0.42) were larger than those of traditional CBTs (g = 0.24; beta = .22; 95% CI, .04 to .41; P = .018

264 nd effectiveness of computer-based training (CBT) of different brushing techniques (Fones versus Bass

265 The ability of cord blood transplantation (CBT) to prevent relapse depends partly on donor natural

266 after unrelated cord blood transplantations (CBTs).

267 was compared with wait-listing/no treatment, CBT significantly improved primary anxiety symptoms, rem

268 not significantly differ between treatments (CBT: 10.2, escitalopram: 11.1, duloxetine: 11.2).

269 not significantly differ between treatments (CBT: 41.9%, escitalopram: 46.7%, duloxetine: 54.7%).

270 The average annual cost of trial CBT per participant was pound343 (SD 129).

271 bones) and compared to chicken breast trim (CBT).

272 ned OCD participants (CBT-only plus waitlist-CBT) also showed a 16.2% (p=0.004) post-CBT decrease in

273 ased CBT with minimal therapist support (web-CBT group), or treatment as usual (TAU group) and were f

274 nts (-12.9 to 38.8; p=0.33) lower in the web-CBT group than in the TAU group.

275 oints (0.1 to 3.7; p=0.036) lower in the web-CBT group than in the TAU group.

276 ephone-CBT group, 99 (54%) of 185 in the web-CBT group, and 105 (56%) of 187 in the TAU group.

277 11 in the telephone-CBT group, 15 in the web-CBT group, and 15 in the TAU group.

278 hone-CBT group, in 62 (63%) of 99 in the web-CBT group, and in 48 (46%) of 105 in the TAU group.

279 depressive disorder to sertraline or weekly CBT for 16 weeks.

280 Only within the oxycline were CBT-based pH values close to in situ pH.

281 When CBT was compared with wait-listing/no treatment, CBT sig

282 et rapid, implicit threat reactions, whereas CBT may target slowly deployed threat responses.

283 l intervention, we first established whether CBT was inferior to short-term psychoanalytical psychoth

284 The order in which CBT and antidepressant medication were sequentially comb

285 At the second winter, CBT-SAD was associated with a smaller proportion of SIGH

286 Improvements associated with CBT were found on the primary outcome measures relating

287 cal effects of prefrontal tDCS combined with CBT for depression.

288 hreshold treatment alternative compared with CBT for adults with BED.

289 Compared with CBT, sertraline treatment resulted in lower QIDS-C depre

290 een various medications and comparisons with CBT represent a need for research in the field.

291 ion to medication and treatment failure with CBT.

292 ts were common with medications but not with CBT and were not severe.

293 nectivity was associated with remission with CBT and treatment failure with medication, whereas negat

294 r patients who do not achieve remission with CBT, as is adding CBT after antidepressant monotherapy.

295 patients who did not achieve remission with CBT, escitalopram was added (CBT plus medication group)

296 When simple thiols reacted reversibly with CBT, the thioimidate monoadduct was approximately 80-fol

297 y better with sertraline treatment than with CBT.

298 pleted 12 weeks of randomized treatment with CBT or antidepressant medication.

299 ugh "OCFighter" or guided self-help (written CBT materials with limited telephone or face-to-face sup

300 atio of $100 000 or less per QALY at 1 year; CBT had a 73% to 77% likelihood at 5 years.